Search
for
Sort by
Research 30 of 1000+
- La clinoïdectomie antérieure extra-durale dans l'abord des méningiomes sus-tentoriels de la base du crâne. À propos d'une série de 142 cas
- Un nuevo anovulador antiandrogénico
- The antiandrogen cyproterone acetate: discovery, chemistry, basic pharmacology, clinical use and tool in basic research<sup>*</sup>
- Pharmacology and Potential Use of Cyproterone Acetate
- Cyproterone Acetate in the Treatment of Sexual Disorders: Pharmacological Base and Clinical Experience
- Metabolic Effect at Six and Twelve Months of Cyproterone Acetate (2 mg) Combined with Ethinyl Estradiol (35 μg) in 31 Patients
- Cyproterone Acetate Quantification in Human Plasma by High-performance Liquid Chromatography Coupled to Atmospheric Pressure Photoionization Tandem Mass Spectrometry
- Caractéristiques épidémio-cliniques, facteurs de risque, étiologies de l’hirsutisme : à propos de 84 cas
- Contraception hormonale et cancer du sein : Une question de contexte
- DHEA : why, when, and how much ? D’après la conférence de Bruno Allolio (Wuerzburg), 50e Journées internationales d’endocrinologie clinique Henri-Pierre KLOTZ, septembre 2007
- Die kontrazeptive Betreuung androgenisierter Frauen mit einem niedrig dosierten cyproteronacetathaltigen Einphasenpräparat
- Die Behandlung androgenisierter Frauen mit intramuskulär applizierbarem Cyproteronacetat
- Cyproteronacetat zur topischen Therapie androgenabhängiger Erkrankungen
- Osteoanabole Östrogentherapie bei einem transsexuellen Mann
- Biological Profile of Cortexolone 17a-Propionate (CB-03-01), a New Topical and Peripherally Selective Androgen Antagonist
- Pharmacological Profile of 9,11-Dehydrocortexolone 17α-Butyrate (CB-03-04), a New Androgen Antagonist with Antigonadotropic Activity
- Sexual Hormones in Human Skin
- Behandlung mit Antiandrogenen in der Gynäkologie
- Liarozole—a novel treatment approach for advanced prostate cancer: results of a large randomized trial versus cyproterone acetate
- Risk of meningioma among users of high doses of cyproterone acetate as compared with the general population: evidence from a population-based cohort study
- The influence of long-term treatment with cyproterone acetate or a cyproterone acetate-ethinyl oestradiol combination on androgen levels in blood of hirsute women
- Androstanediolglucuronide: A parameter for peripheral androgen activity before and during therapy with cyproterone acetate
- Comparison of cyproterone acetate plus ethinyl estradiol and finasteride in the treatment of hirsutism
- Use of cyproterone acetate (CPA) in the treatment of acne, hirsutism and virilism
- Use of high dose cyproterone acetate and risk of intracranial meningioma in women: cohort study
- The use of cyproterone acetate/ethinyl estradiol in hyperandrogenic skin symptoms – a review
- Prescription Appropriateness of Cyproterone Acetate/Ethinylestradiol in Primary Care: A Population-Based Study in Italy
- The Effects of Metformin, Ethinyl Estradiol/Cyproterone Acetate, and Metformin Ethinyl Estradiol/Cyproterone Acetate Combination Therapy on Carotid Artery Intima-media Thickness in Patients with Polycystic Ovary Syndrome
- The importance of adequate serum ferritin levels during oral cyproterone acetate and ethinyl oestradiol treatment of diffuse androgen-dependent alopecia in women
- Physician Awareness of the Safe Use of Cyproterone Acetate in Europe: A Survey on the Effectiveness of Additional Risk Minimization Measures